DCGI approves KEYTRUDA to treat triple negative breast cancer, renal cell carcinoma
KEYTRUDA is now approved for 14 indications across eight tumour types in India
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.